Device: kera-x    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
168Ehlers-Danlos syndrome1

168. Ehlers-Danlos syndrome    [ 7 clinical trials,   16 drugs,   (DrugBank: 8 drugs),   9 drug target genes,   54 drug target pathways]
Searched query = "Ehlers-Danlos syndrome", "EDS", "cEDS", "hEDS", "clEDS", "vEDS", "kEDS", "aEDS", "dEDS", "DDEDS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 7 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01307527
(ClinicalTrials.gov)
November 20081/3/2011Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VIBrittle Cornea Syndrome;Ehlers-Danlos Syndrome Type 6Drug: Riboflavin;Device: Kera-XHadassah Medical OrganizationNULLEnrolling by invitation18 YearsN/ABoth1N/AIsrael